Scop: Investigarea unei potenţiale relaţiii între raportul neutrofile /limfocite (NLR) şi procentul metastazării nodurilor limfatice nonsantinelă (NSLN) în cancerul mamar timpuriu. Metode: Datele clinice ale pacienţilor cu cancer mamar invaziv în stadiu incipient clinic (cT1-3,N0), care au beneficiat de biopsie ghidată cu substanţă de contrast şi limfoscintigrafic între Aprilie 2015 şi Ianuarie 2017, au fost prelucrate retrospectiv. Valoarea NLR la întregul grup de pacienţi, indiferent de statusul NSLN, a fost înregistrată pre-tratament. Rezultate: Un număr total de 178 de pacienţi cu vârsta medie de 51,65±10,93 ani au fost incluşi în studiu. NLR a fost statistic semnificativ la pacienţii cu NSLN invadat (p=0.011). Invazia limfovasculară şi extensia extracapsulară la nivelul nodului limfatic santinelă (SLN) au intervenit mai frecvent la pacienţii NSLN invadat (p<0.05). Riscul de metastazare în nodurile limfatice (N1) la pacienţii cu invazie limfovasculară a fost semnificativ mai ridicat (OR 3,733 (95% CI: 1,05-13,24). Riscul de metastazare la nivelul NSLN a fost de circa 10 ori mai ridicat la pacienţii cu invazie capsulară comparativ cu cei fără invazie capsulară (OR 10, 267; 95% CI: 2, 12) . Concluzii: İnvazia limfovasculară, extensia extracapsulară şi NLR reprezintă parametrii predictivi ai pozitivităţii NSLN. Calcularea preoperatorie a NLR reprezintă un instrument predictiv util în ceea ce priveşte estimarea riscului de invazie malignă a NSLN.
Introduction
Axillary lymph node dissection is performed in invasive breast cancer patients who had positivity of sentinel lymph node biopsy (SLNB) in routine practice. Nonetheless, since 40% to 70% of patients have metastatic axillary lymph nodes only in the sentinel lymph node (SLN), the identification of factors predicting axillary non-sentinel node involvement may reduce unnecessary axillary dissection and reduce morbidity (1) (2) (3) . On the other hand, neutrophil to lymphocyte ratio (NLR), a marker of systemic inflammation, has been studied and reported to be predictive of some types of breast cancer (4, 5) . However, to the best of our knowledge, there is only one study has been conducted on the use of the NLR in the determination of the non-SLN metastasis (6) . Therefore, the objective of this study was to investigate the relationship between NLR and non-SLN metastasis in early stages of breast cancer.
Methods
This study was conducted retrospectively. Records of patients with clinically early stage (cT1-T3, N0) invasive breast cancer who underwent SLNB with blue dye or in combination with blue dye and lymphoscintigraphy between April 2015 and January 2017 were noted.
Patients who had any of the following criteria were excluded; cT3-T4 carcinoma, distant metastasis at initial diagnosis, systemic neoadjuvant chemoradiotherapy, having active infection, steroid usage. Clinical and demographical features of the patients including age, tumor size, histologic grade, number of positive and negative lymph nodes, number of positive and negative Non-SLN, ER, PR status, HER2 status, LVI presence, Ki67 index and preoperative NLR.
Each patient underwent planar lymphocytography with Tc99m-Nanocolloid (SENTI-SCINT-KIT) 2-6 hours before the operation in the department of nuclear medicine. A total of 200 MBq / ml periaerolar was administered subdermally with four injections (50 Mbq/0.25 ml in each injector). Dynamic static imaging was performed following injections. The skin projection of the SLN was marked. 5 mL of 1% methylene blue was injected-subaerosol and subdermal-immediately after general anesthesia before the onset of the disease. Following the injection, massaging from the injected area to axillary region was applied to accelerate the lymphatic flow. A transverse skin incision was made 1 cm below the armpit hairline 7-10 minutes after the end of the injection procedure. Painted canal and lymph nodes were determined by passing through the clavipectoral fascia. The lymph nodes were ex vivo counted by gamma probe after the procedure and the findings were noted. The axillar region was scanned with a gamma probe. More than 10% of the activity value in the highest counted lymph node was subtracted from the lymph node counts. Removed lymph nodes were sent to the patho-logy clinic for frozen examination and the planned operation was performed. Level 1 and Level 2 axillary lymph node dissection were performed in patients with SLNB positive.
Blood count data preoperatively were collected retrospectively. NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count. 
Results
A total of 178 patients with a mean age of 51,65±10,93 years were included. Clinical features of the patients are summarized in Table 1 .
Of the patients, 47 (26.4%) had SLN metastasis. In the group of patients with SLN metastasis, 19 patients (40.4%) had an additional non-SLN metastasis. Tumor size, NLR, and SLN size of the patients with and without non-SLN metastasis are shown in Table 2 . NLR was Fig. 1 . The NLR's ROC curve was 0.7 (95% CI 0.5-0.8). Sensitivity to non-SLN metastasis positivity in patients with NLR> 1.80 was 68.42%; specificity 71.43%; positive predictive value of 61.9% and negative predictive value of 76.92%. In the obtained ROC curve, the underlying area was 71.9% and the standard error was 7.8%.
Factors affecting the non-SLN metastasis -LVI, Positive SLN extracapsular extension, and NLR-were evaluated by Enter Logistic regression analysis.The model was meaningful and the explanatory coefficient of the model (76.6%) was acceptable. The effect of positive SLN extracapsular extension was statistically significant (p <0,01). The ODDS ratio of the effect on non-SLN metastases was found to be 7,309 (95% CI: 1.64-32.55) times higher. The ODDS value of the effect of the level of LVI was 4,092 (95% CI: 0,876-19,118) and the ODDS ratio of the effect of the NLR level of 1,80 and higher was found to be 4,076 (95% CI: 0,896-18,554) ( Table 4) .
Discussion
In this study, we aimed to explore whether the NLR is a predictive tool for non-SLN metastasis. According to our results, we have two main findings. First, NLR was statistically significant in the non-SLN positive patients. Aside from the NLR, LVI and extracapsular extension of SLN were found to be predictive for non-SLN metastasis. The NLR, obtained by the number of neutrophils and lymphocytes, is used as a simple tool evaluating systemic inflammation. Many studies have shown that NLR is correlated with the prognosis in breast, colorectal, gastric, pancreas, hepatocellular, and renal cancers. Neutrophils are known to promote tumor cell proliferation, angiogenesis, and distant metastasis as well as lymphocytes play a central role in the immune response to tumor cells. From this point of view, NLR is predicted to be associated with prognosis (4,7-9).
As regards the association between NLR and breast cancer, there are some studies in the literature. In a large cohort study of 442 patients with breast cancer, it was shown that patients with high NLR (≥2.5) had statistically significantly lower survival times than those with low NLR (<2.5) (4). Koh et al. (9) have shown that high NLR (> 4) is associated with larger tumor, high grade, and distant metastasis. There is only one report whether the NLR is predictive of non-SLN metastasis.
Laohawiriyakamol et al. (6) There are several studies taking into account the clinicopathologic factors predicting non-SLN metastasis (10) (11) (12) . LVI and number of positive and negative SLNs and their sizes are predic- (13) . Likewise, in our study LVI and extracapsular invasion were found to be the independent risk factors.We have some important drawbacks for this study.
Collecting the data retrospectively is the main limitation. Relatively small sample size compared with the previous studies is a limitation as well.
Conclusion
In the light of our results, LVI, extracapsular extension and NLR are the predictive parameters of non-SLN positivity. Pre-surgical NLR is a useful diagnostic tool for predicting non-SLN metastasis. Further studies considering the NLR and non-SLN metastasis in different stages of breast cancer in cohort designs are awaited.
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